These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Severe metabolic acidosis in a diabetic during treatment with phenformin and allopurinol. A result of drug interaction?]. Strandgaard S Ugeskr Laeger; 1970 Sep; 132(39):1834-6. PubMed ID: 5470908 [No Abstract] [Full Text] [Related]
63. [Tolbutamide controversy; falling into the pit sobbing]. Touber JL Ned Tijdschr Geneeskd; 1975 Nov; 119(46):1821-8. PubMed ID: 1107858 [No Abstract] [Full Text] [Related]
65. The treatment of diabetes mellitus with oral hypoglycaemic drugs. Duncan LJ; Clarke BF; Munro JF Curr Med Drugs; 1965 Jun; 5(10):23-32. PubMed ID: 5878054 [No Abstract] [Full Text] [Related]
66. Misunderstanding or error? The UGDP report after four years. Marigo S; Adezati L; Burnetti P; Pozza G; Robba L; Urbinati G Acta Diabetol Lat; 1974; 11(5):357-422. PubMed ID: 4156992 [No Abstract] [Full Text] [Related]
67. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799 [TBL] [Abstract][Full Text] [Related]
68. [Do oral antidiabetics play a part in the cardiovascular mortality of diabetics? Apropos of the University Group Diabetes Program report and the controversies it has raised]. Canivet J; Deuil R; Eschwege E; Hazard J; Lubetzki J; Tchobroutsky G; Valleron A Presse Med (1893); 1971 Dec; 79(53):2437-44. PubMed ID: 5156529 [No Abstract] [Full Text] [Related]
69. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP). Seltzer HS Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722 [No Abstract] [Full Text] [Related]
70. A note on tolbutamide and diabetes. Med Lett Drugs Ther; 1970 Jul; 12(14):60. PubMed ID: 4935987 [No Abstract] [Full Text] [Related]
71. [Pancytopenia in diabetes mellitus treatment with tolbutamide?]. Traumann KJ; Grom E; Schwarzkopf H Dtsch Med Wochenschr; 1975 Feb; 100(6):250-1. PubMed ID: 1112246 [TBL] [Abstract][Full Text] [Related]
72. Status of problem of usage of tolbutamide. Preliminary statements. Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867 [No Abstract] [Full Text] [Related]
73. Seminars on diabetes. II. Principles of management. Can Med Assoc J; 1971 Nov; 105(9):972-3 passim. PubMed ID: 5150198 [No Abstract] [Full Text] [Related]
76. Tolbutamide and the heart. Ricketts HT JAMA; 1972 Nov; 222(9):1179-80. PubMed ID: 4678067 [No Abstract] [Full Text] [Related]
77. Oral anti-diabetic agents: how do they stand after the university group diabetes program (UGDP)? Drug Ther Bull; 1977 May; 15(10):37-9. PubMed ID: 326507 [No Abstract] [Full Text] [Related]
78. [Effect of a new oral drug in the treatment of diabetes mellitus]. Lubetzki J Diabete; 1971; 19(3):185-90. PubMed ID: 5002990 [No Abstract] [Full Text] [Related]